Preferreds sold at $1,000 with warrants for about 10.8 million shares
By Devika Patel
Knoxville, Tenn., March 10 – International Stem Cell Corp. arranged a $6.31 million private placement of convertible preferred stock on March 9, according to an 8-K filed Thursday with the Securities and Exchange Commission. Rodman & Renshaw is the agent.
The company will sell 2,000 series I-1 preferreds at $1,000 per preferred and 4,310 series I-2 preferreds at $1,000 per preferred. The series I-2 preferreds will be sold to chief executive officer and co-chairman Andrey Semechkin.
Each preferred will initially be convertible into common shares at $1.75 per share.
Investors also will receive series A warrants for about 3.6 million shares, series B warrants for about 3.6 million shares and series C warrants for about 3.6 million shares. The A warrants are exercisable at $3.64 for five years. The B warrants are exercisable at $1.75 for six months. The C warrants are exercisable at $1.75 for one year.
The strike prices and conversion price of $3.84 and $1.75 are 5.21% and 54.43% discounts to the $3.84 closing share price on March 8.
Settlement is expected March 15.
International Stem Cell is a biotechnology company based in Carlsbad, Calif.
Issuer: | International Stem Cell Corp.
|
Issue: | Series I-1 convertible preferred stock, series I-2 convertible preferred stock
|
Amount: | $6.31 million
|
Price: | $1,000
|
Conversion price: | $1.75
|
Warrants: | For about 10.8 million shares
|
Warrant expiration: | Five years, six months, one year
|
Warrant strike price: | $3.64, $1.75
|
Agent: | Rodman & Renshaw
|
Investor: | Andrey Semechkin (for $4.31 million)
|
Pricing date: | March 9
|
Settlement date: | March 15
|
Stock symbol: | OTCBB: ISCO
|
Stock price: | $3.84 at close March 8
|
Market capitalization: | $8.63 million
|
|
Series I-1
|
Amount: | $2 million
|
Shares: | 2,000
|
|
Series I-2
|
Amount: | $4.31 million
|
Shares: | 4,310
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.